Therapeutic efficacy of danazol in myelodysplastic syndromes
- 1 September 1988
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 24 (9) , 1481-1489
- https://doi.org/10.1016/0277-5379(88)90339-2
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Danazol in the treatment of myelodysplastic syndromesEuropean Journal of Haematology, 1987
- Danazol Therapy in Acquired Idiopathic Sideroblastic AnemiaActa Haematologica, 1987
- Efficacy of danazol in pure red cell aplasiaAmerican Journal of Hematology, 1986
- Danazol binds to progesterone receptors and inhibits the growth of human endometrial cancer cells in vitroAmerican Journal of Obstetrics and Gynecology, 1986
- EVOLUTION OF THE MYELODYSPLASTIC SYNDROMESBritish Journal of Haematology, 1986
- Management of myelodysplastic syndromesThe American Journal of Medicine, 1986
- Danazol and Myelodysplasic SyndromesAnnals of Internal Medicine, 1986
- Danazol Therapy in MyelodysplasiaAnnals of Internal Medicine, 1985
- Proposals for the classification of the myelodysplastic syndromesBritish Journal of Haematology, 1982
- DanazolAnnals of Internal Medicine, 1982